The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPharos Energy Regulatory News (PHAR)

Share Price Information for Pharos Energy (PHAR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 23.20
Bid: 23.10
Ask: 23.60
Change: 0.30 (1.31%)
Spread: 0.50 (2.165%)
Open: 21.90
High: 23.20
Low: 21.90
Prev. Close: 22.90
PHAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

RESPONSE TO SPECULATION ABOUT OPHIR ENERGY PLC

6 Mar 2019 07:00

RNS Number : 9537R
Soco International PLC
06 March 2019
 

 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION.

 

THIS IS AN ANNOUNCEMENT FALLING UNDER RULE 2.8 OF THE UK CITY CODE ON TAKEOVERS AND MERGERS (THE "CODE")

 

SOCO International plc

("SOCO" or the "Company" or, together with its subsidiaries, the "Group")

 

6 March 2019

RESPONSE TO SPECULATION ABOUT OPHIR ENERGY PLC

In response to speculation in the market relating to SOCO's potential interest in a combination with Ophir Energy plc ("Ophir"), the Company makes the following statement.

 

SOCO has for some time believed that a combination with Ophir would create significant and long-term value for shareholders in both companies.

 

On 17 January 2019, SOCO tabled a formal proposal to Ophir's Board regarding an all-share combination of SOCO and Ophir. The Board of Ophir unanimously rejected SOCO's proposal on 22 January 2019.

 

In light of Ophir's subsequent announcement of a recommended all cash offer of 55 pence from PT Medco Energi Global PTE Ltd ("Medco"), SOCO believes that a share-based combination with Ophir would currently be challenging to execute and so would represent an unacceptable level of risk for SOCO shareholders.

 

SOCO remains committed to its strategy of shareholder value creation through sustainable cash returns to shareholders and growth of the business. The SOCO team, which has a track record of delivering shareholder value through asset acquisition and monetisation, delivering large scale developments, and returning capital to shareholders, evaluates M&A opportunities with reference to its strict strategic, financial and operational criteria. Any transaction will be pursued only if it is determined by SOCO's Board to be in the best interest of shareholders.

 

As a result, SOCO confirms that it does not intend to make an offer for Ophir and is consequently bound by the restrictions set out under Rule 2.8 of the Code.

 

For the purposes of Note 2 on Rule 2.8 of the Code, SOCO reserves the right to announce or participate in an offer or possible offer for Ophir, and/or to take any other action which would otherwise be restricted under Rule 2.8 of the Code, within six months after the date of this announcement:

 

i. in the event that the Medco offer has been withdrawn or lapsed, with the agreement of the Board of Ophir; or

ii. if Ophir announces a "whitewash" proposal (see Note 1 of the Notes on Dispensations from Rule 9 of the Code) or a reverse takeover (as defined in the Code); or

iii. if there has been a material change of circumstances (as determined by the Panel on Takeovers and Mergers (the "Panel")).

In accordance with Rule 26.1 of the Code, a copy of this announcement will be available on SOCO's website (https://www.socointernational.com) by no later than 12 noon (London time) on the business day following the date of this announcement. The content of the website referred to in this announcement is not incorporated into, and does not form part of, this announcement.

 

 

Enquiries:

SOCO International plc

Tel: +44 (0) 20 7747 2000

Ed Story, President and Chief Executive Officer

Jann Brown, Managing Director and Chief Financial Officer

Mike Watts, Managing Director

Sharan Dhami, Group Investor Relations Manager

 

Evercore Partners International LLP

 

Tel: +44 (0) 20 7653 6000

David Waring / Edward Banks / Aditya Lohia

 

Camarco

 

Tel: +44 (0) 20 3757 4980

Billy Clegg / Owen Roberts

 

 

Important Notice

Evercore Partners International LLP ("Evercore"), which is authorised and regulated in the United Kingdom by the Financial Conduct Authority, is acting as financial adviser exclusively for SOCO and no one else in connection with the matters referred to in this announcement and will not regard any other person as its client in relation to the matters referred to in this announcement and will not be responsible to anyone other than SOCO for providing the protections afforded to clients of Evercore, nor for providing advice in relation to the matters referred to in this announcement. Neither Evercore nor any of its subsidiaries, branches or affiliates owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract or in tort, under statute or otherwise) to any person who is not a client of Evercore in connection with this announcement, any statement contained therein or otherwise.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RSPLFFELVRIEIIA
Date   Source Headline
10th May 20247:00 amRNSTransaction in Own Shares
9th May 20247:00 amRNSTransaction in Own Shares
8th May 20247:00 amRNSTransaction in Own Shares
7th May 20247:00 amRNSTransaction in Own Shares
3rd May 20247:00 amRNSDirectorate Change
2nd May 20247:00 amRNSTransaction in Own Shares
1st May 20247:30 amRNSGrant of Share Awards to Directors/PDMRs
30th Apr 20244:57 pmRNSTotal Voting Rights
30th Apr 20247:30 amRNSDirectors/PDMR Shareholdings
30th Apr 20247:00 amRNSTransaction in Own Shares
29th Apr 20247:00 amRNSTransaction in Own Shares
25th Apr 20244:20 pmRNS2023 Annual Report and Accounts and Notice of AGM
23rd Apr 20247:00 amRNSTransaction in Own Shares
22nd Apr 20247:00 amRNSTransaction in Own Shares
17th Apr 20247:00 amRNSTransaction in Own Shares
15th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20247:00 amRNSTransaction in Own Shares
11th Apr 20247:00 amRNSTransaction in Own Shares
8th Apr 20247:00 amRNSTransaction in Own Shares
5th Apr 20247:00 amRNSTransaction in Own Shares
4th Apr 20247:00 amRNSTransaction in Own Shares
3rd Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 202410:21 amRNSTOTAL VOTING RIGHTS REPLACEMENT
2nd Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 20247:00 amRNSTotal Voting Rights
28th Mar 20249:20 amRNSInvestor Presentation via Investor Meet Company
28th Mar 20247:30 amRNSShare Purchases by Directors
28th Mar 20247:00 amRNSTransaction in Own Shares
27th Mar 20247:01 amRNSDirectorate Change
27th Mar 20247:00 amRNS2023 Preliminary Results
27th Mar 20247:00 amRNSTransaction in Own Shares
26th Mar 20247:00 amRNSTransaction in Own Shares
25th Mar 20241:22 pmRNSStandard form for notification of major holdings
25th Mar 20247:00 amRNSTransaction in Own Shares
21st Mar 20244:35 pmRNSBlock Listing Six Monthly Return
20th Mar 20247:00 amRNSTransaction in Own Shares
19th Mar 20247:00 amRNSTransaction in Own Shares
18th Mar 20247:00 amRNSTransaction in Own Shares
14th Mar 20247:00 amRNSTransaction in Own Shares
13th Mar 20247:00 amRNSTransaction in Own Shares
12th Mar 20247:00 amRNSTransaction in Own Shares
11th Mar 20247:00 amRNSTransaction in Own Shares
8th Mar 20247:00 amRNSTransaction in Own Shares
7th Mar 20247:00 amRNSTransaction in Own Shares
6th Mar 20247:00 amRNSTransaction in Own Shares
5th Mar 20247:00 amRNSTransaction in Own Shares
4th Mar 20247:00 amRNSTransaction in Own Shares
1st Mar 20244:35 pmRNSTotal Voting Rights
29th Feb 20247:00 amRNSTransaction in Own Shares
28th Feb 20247:30 amRNSDirectors/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.